Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: HORIZON (Effect of Pelacarsen on Cardiovascular Outcomes in Patients With Elevated Lipoprotein(a): Primary Results From the Lp(a) HORIZON Trial) November 7, 2026 2026 | ACC | Slides | Trial | Video Nissen AHA 2026Download Disclosures: TBD Article Navigation Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: ZEUS (Primary Report of the Ziltivekimab Cardiovascular Outcomes Trial) Dr. Todd Villines and Dr. C. Michael Gibson Discuss: PARAMOUNT (A Randomized Comparison of Personalized Management for Medical and Interventional Therapy Based on Coronary Atherosclerotic Plaque versus Usual Care for Symptomatic Patients With Suspicion of Coronary Artery Disease: Primary Results of the PARAMOUNT Trial)
